Model and Empirical Data-Based Cost-Utility Studies of Continuous Glucose Monitoring in Individuals with Type 1 Diabetes: A Protocol of a Systematic Review on Methodology and Quality.
Lisa Aniek de JongXinyu LiS EmamipourSjoukje van der WerfM J PostmaPeter Ruben van DijkTalitha L FeenstraPublished in: PharmacoEconomics - open (2023)
Now that CGM is being used more broadly in practice, critical appraisal of existing cost-utility methodology and quality is important to inform future cost-utility analyses of CGM in type 1 diabetes in various settings.